RxDoctor Payments Data

Jess Lonner, MD

Orthopaedic Surgery · Bryn Mawr, PANPI 1568499309

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $6,934,167 of the $7,803,388 with a category attached, or 88.9%. Zimmer Biomet accounts for 92.3% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2023 at $3,627,929 and has fallen 80.7% since, to $698,854 in 2025. Among orthopaedic surgery clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$7,803,388in general payments, 2019–2025

Across 463 payments — averaging $16,854 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Zimmer Biomet$7.2M
  • Smith+Nephew$588K
  • Pacira Pharmaceuticals Incorporated$13K
  • Heraeus Medical, LLC.$25
  • Johnson & Johnson$15
$350,663in research payments, 2019–2025

Across 33 payments — averaging $10,626 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Zimmer Biomet$304K
  • Smith+Nephew$46K

What the payments were for

  • Royalty or licence$6,934,16789%
  • Consulting fees$668,5389%
  • Speaking & faculty fees$1,6600%
  • Travel & lodging$48,8361%
  • Food & beverage$7,2480%
  • Education$112,1881%
  • Other$30,7520%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,803,388 in reported general payments places this provider in the 95th percentile of 1,048 orthopaedic surgery providers in Pennsylvania.

See all orthopaedic surgery providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$480,790
Medicare patients
698
Services billed
3,471

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone Hcl248$1,399
Meloxicam210$547
Celecoxib33$533
Tramadol Hcl137$347
Amoxicillin91$275
Cyclobenzaprine Hcl22$192
Ondansetron Hcl72$171
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen20$85
Ciprofloxacin Hcl11$77
Methylprednisolone13$64
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim17$50
Ondansetron OdtOndansetron11$44
Clindamycin Hcl19$34

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Bryn Mawr

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →